Find the latest Nuformix plc (NFX.L) stock quote, history, news and other vital information to help you with your stock trading and investing.

Nuformix is a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing

Nuformix Plc Ord 0.05p is listed on the London Stock Exchange trading with ticker code NFX.L. It has a market capitalisation of £2.02m, with approximately 1.67b shares in issue. Over the last...

Apr 4, 2025 · Latest Nuformix PLC (NFX:LSE) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.

Mar 18, 2025 · Stock analysis for Nuformix PLC (NFX:London) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Dec 13, 2024 · Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care.

6 days ago · Nuformix plc is a United Kingdom-based pharmaceutical development company. The Company is engaged in targeting unmet medical needs in fibrosis and oncology via drug repurposing.

Find real-time NFX.L share price, quotes, news and analyst forecast on eToro. Get insights into market trends and stock performance.

5 days ago · Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care.

Find the latest Nuformix plc (NFX.L) stock quote, history, news and other vital information to help you with your stock trading and investing.